High Tide Inc. (HITI) - Long-Term Debt to Capital

hightideinc.com - graphic logo of issuer HITI

The price action history of High Tide Inc. (HITI) serves as an indicator for a business that relies on an extensive pharmacy network and strict licensing control, which, combined with a stable cash flow, minimizes financial risks. The current figure is 0.94. The company's dominance is driven by the implementation of advanced retail analytics and loyalty programs that optimize pricing within the discount club segment.

High Tide Corp (HITI) - Long-Term Debt to Capital from 07/04/2022 to 10/29/2026

Analytical breakdowns for High Tide Inc. (HITI)

- current price and projected stock value:
Share Price High Tide Inc|HITI - Analyst Consensus Forecast
- market capitalization indicators:
Market Capitalization High Tide Inc.|HITI - Total Company Value
- company book value details:
Accounting Value of a Share High Tide|HITI - Book Capitalization|Market Cap to Net Assets Ratio hightideinc.com|HITI - Aggregate Company Assets
- company liabilities and liquidity data:
Debt to Capital High Tide Inc.|HITI - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital hightideinc.com|HITI - Company Aggregate Debts|Debts to Book Capitalization Ratio High Tide Inc.|HITI - Company Long-Term Debts|Company Short-Term Debts High Tide
Summary company analysis:High Tide Inc (HITI)
Original product of hightideinc.com

This ratio measures the proportion of long-term liabilities relative to equity, allowing for an assessment of the issuer's financial stability and debt load. The current value of 0.94, combined with the automation of retail processes at High Tide Inc. (HITI), reflects the ratio of long-term debt to equity, determining the company's ability to fund its professional staff without a critical dependence on borrowed funds.

Key competitors

Long-Term Debt to Capital Ratio INDV (Indivior plc)|Long-Term Debt to Capital COLL|Long-Term Debt to Capital Cronos Corp (CRON)|Long-Term Debt to Equity Canopy Growth CGC|Long-Term Debt to Capital Coefficient ACB|Achieve Life Sciences, Inc. - Long-Term Debt to Capital|Skye Bioscience Inc. (SKYE) - Long-Term Debt to Equity Ratio|Anebulo (ANEB) - Long-Term Debt to Equity|Long-Term Liabilities to Capital InterCure (INCR)|Long-Term Debt to Equity Ratio NTRB|NSRX: Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital IGC|MIRA: Long-Term Liabilities to Equity|Long-Term Debt to Capital FLGC (Flora Growth Corporation)|Long-Term Debt to Capital IM Cannabis Corp IMCC|ADIL - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient ARTL (Artelo Biosciences)|ensysce.com (ENSC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Titan Pharmaceuticals, Inc.|GNLN (Greenlane Holdings Inc) - Long-Term Debt to Capital|INM: Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital AKAN|Ratio of Long-Term Indebtedness to Capital enveric.com|Long-Term Debt to Capital BGXX (Bright Green Corporation)|Long-Term Indebtedness to Equity hempaccoinc.com